PAX5 and precursor B-cell acute lymphoblastic leukemia: In fact, PAX5 expression is associated with the most common non-Hodgkin B-cell malignancies including: diffused large B-cell lymphoma (DLBCL) [53,54]; chronic lymphocytic leukemia [55]; and B-cell acute lymphoblastic leukemia (B-ALL) [55].